Boston Common Asset Management LLC increased its position in shares of Xylem Inc. (NYSE:XYL – Free Report) by 7.5% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 145,639 shares of the industrial products company’s stock after buying an additional 10,119 shares during the period. Xylem comprises approximately 1.1% of Boston Common Asset Management LLC’s holdings, making the stock its 23rd largest holding. Boston Common Asset Management LLC’s holdings in Xylem were worth $17,404,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also recently made changes to their positions in the company. Commonwealth Retirement Investments LLC purchased a new stake in Xylem in the fourth quarter worth about $27,000. Wexford Capital LP purchased a new position in Xylem during the 3rd quarter valued at about $27,000. Global Assets Advisory LLC purchased a new position in Xylem during the 1st quarter valued at about $40,000. FWL Investment Management LLC bought a new stake in shares of Xylem in the 2nd quarter valued at about $43,000. Finally, Entrust Financial LLC bought a new stake in shares of Xylem in the 4th quarter valued at about $45,000. 87.96% of the stock is currently owned by institutional investors.
Insider Buying and Selling at Xylem
In related news, CAO Geri-Michelle Mcshane sold 4,269 shares of the business’s stock in a transaction on Thursday, May 7th. The stock was sold at an average price of $117.46, for a total transaction of $501,436.74. Following the transaction, the chief accounting officer directly owned 3,605 shares in the company, valued at $423,443.30. The trade was a 54.22% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Jerome A. Peribere bought 1,210 shares of Xylem stock in a transaction that occurred on Monday, May 4th. The shares were acquired at an average cost of $116.61 per share, for a total transaction of $141,098.10. Following the completion of the transaction, the director directly owned 27,209 shares in the company, valued at $3,172,841.49. This represents a 4.65% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. 0.32% of the stock is owned by insiders.
Xylem Trading Up 0.1%
Xylem (NYSE:XYL – Get Free Report) last announced its earnings results on Tuesday, April 28th. The industrial products company reported $1.12 earnings per share for the quarter, beating the consensus estimate of $1.09 by $0.03. Xylem had a net margin of 10.79% and a return on equity of 11.26%. The company had revenue of $2.12 billion during the quarter, compared to the consensus estimate of $2.11 billion. During the same period last year, the firm earned $1.03 earnings per share. Xylem’s revenue was up 2.7% compared to the same quarter last year. Xylem has set its FY 2026 guidance at 5.350-5.600 EPS. As a group, sell-side analysts forecast that Xylem Inc. will post 5.51 EPS for the current fiscal year.
Xylem Dividend Announcement
The firm also recently disclosed a quarterly dividend, which was paid on Thursday, June 25th. Stockholders of record on Thursday, May 28th were given a $0.43 dividend. The ex-dividend date of this dividend was Thursday, May 28th. This represents a $1.72 dividend on an annualized basis and a dividend yield of 1.4%. Xylem’s dividend payout ratio (DPR) is presently 42.79%.
Analysts Set New Price Targets
A number of equities analysts have recently issued reports on XYL shares. JPMorgan Chase & Co. dropped their price objective on shares of Xylem from $170.00 to $160.00 and set an “overweight” rating on the stock in a research note on Thursday, April 16th. Citigroup reduced their price objective on shares of Xylem from $174.00 to $168.00 and set a “buy” rating for the company in a research note on Wednesday, April 29th. Jefferies Financial Group raised Xylem from a “hold” rating to a “buy” rating and increased their target price for the company from $130.00 to $140.00 in a research report on Thursday, June 25th. Barclays cut their price target on Xylem from $156.00 to $154.00 and set an “overweight” rating on the stock in a report on Wednesday, April 29th. Finally, Stifel Nicolaus decreased their price objective on Xylem from $163.00 to $159.00 and set a “buy” rating for the company in a research note on Wednesday, April 29th. Eight research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company’s stock. Based on data from MarketBeat, Xylem presently has an average rating of “Moderate Buy” and a consensus target price of $153.31.
Get Our Latest Analysis on XYL
About Xylem
Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.
The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.
Recommended Stories
- Five stocks we like better than Xylem
- Strait of Hormuz Tensions Spike Tanker Trade: These 2 Stocks Are Set to Benefit
- Shopify’s Quiet AI Strategy Could Be Its Biggest Advantage Yet
- Why These 3 Nuclear ETFs Are Getting a Fresh Look as AI Power Demand Rises
- 3 Aerospace Suppliers That Could Benefit as Aircraft Makers Face Bottlenecks
Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYL – Free Report).
Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.
